The global newborn screening market size attained a value of USD 1.20 billion in 2023. The market is likely to grow at a CAGR of 9% during the forecast period of 2024-2032, likely to attain a value of USD 2.60 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The introduction of various measures by governments to prevent the risk of disability and disease among infants is aiding the market growth. For instance, the Kerala government in India announced that it would initiate universal Comprehensive Newborn Screening (CNS) for newborns in public health facilities in the state in June 2018. Moreover, the advancing healthcare industry in middle- and low-income countries is increasing the accessibility to screening for newborn babies, which is catalysing the market growth. As the treatments are increasingly becoming cost-effective owing to technological advancements, the demand for newborn screening among all socioeconomic classes is increasing. The growing awareness regarding the importance of screening for newborn babies among parents, as it can potentially lead to adversaries such as learning disabilities, autism, retardation, dyslexia, and behavioural abnormalities, among others, is also surging the demand for newborn screening, therefore strengthening the market growth.
Newborn screening refers to screening tests of infants to detect any disease or health adversaries that can be treated after identification. It is conducted through blood tests, heart screening, and hearing screening to identify underlying health conditions of an infant to improve the overall quality of its life.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major technologies of newborn screening are:
The market can be broadly categorised on the basis of its test types into:
Based on product, the market is divided into:
The EMR report looks into the regional markets of newborn screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of complex and advanced diagnostic and screening methods to identify potential health conditions effectively is propelling the market growth. Moreover, the adoption of innovative technologies to diagnose genetic disorders and asymptomatic diseases for effective treatment of preventable and treatable diseases is augmenting the growth of the newborn screening industry. Although the market may be hindered due to the prevalence of false-positive and false-negative results, the increasing development of innovative and precise testing methods to eliminate the risk of false results is expected to significantly contribute to the market growth.
The rising deployment of components of molecular biology to analyse genetic mechanisms to detect diseases is invigorating the growth of the newborn screening industry. This is increasing the deployment of DNA microarray technology to increase the effectiveness of diagnosis, which is fuelling the market growth. In addition, the increasing research activities to minimise the side-effects of newborn screening methods while expanding the screening to diagnose more diseases is expected to provide impetus to the industry growth.
The report presents a detailed analysis of the following key players in the global newborn screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type
|Breakup by Technology
|Breakup by Test Type
|Breakup by Diseases Type
|Breakup by End User
|Breakup by Region
|Report Price and Purchase Option
|Explore our purchase options that are best suited to your resources and industry needs.
|Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Newborn Screening Market Overview
3.1 Global Newborn Screening Market Historical Value (2017-2023)
3.2 Global Newborn Screening Market Forecast Value (2024-2032)
4 Global Newborn Screening Market Landscape
4.1 Global Newborn Screening Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Newborn Screening Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Global Newborn Screening Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Newborn Screening Market Segmentation
6.1 Global Newborn Screening Market by Product Type
6.1.1 Market Overview
6.1.3 Reagent’s & Assay Kits
6.2 Global Newborn Screening Market by Technology
6.2.1 Market Overview
6.2.2 Tandem Mass Spectrometry
6.2.3 Pulse Oximetry
6.2.4 Enzyme Based Assays
6.2.5 DNA Assays
6.3 Global Newborn Screening Market by Test Type
6.3.1 Market Overview
6.3.2 Dry Blood Spot Test
6.3.3 Critical Congenital Heart Disease (CCHD)
6.3.4 Hearing Screen
6.4 Global Newborn Screening Market by Diseases Type
6.4.1 Market Overview
6.4.2 Critical Congenital Heart Diseases
6.4.3 New-born Hearing Loss
6.4.4 Sickle Cell Disease
6.4.5 Phenylketonuria (PKU)
6.4.6 Cystic Fibrosis (CF)
6.4.7 Maple Syrup Urine Disease
6.5 Global Newborn Screening Market by End User
6.5.1 Market Overview
6.5.2 Clinical Laboratory
6.5.4 Diagnostic Centre’s
6.6 Global Newborn Screening Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Newborn Screening Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Newborn Screening Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Newborn Screening Market
9.1 Market Share by Country
10 Latin America Newborn Screening Market
10.1 Market Share by Country
11 Middle East and Africa Newborn Screening Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 PerkinElmer Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.2 Demant A/S
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.3 Natus Medical Incorporated
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.4 Bio-Rad Laboratories
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.5 Luminex Corporation
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.6 F. Hoffmann-La Roche Ltd.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.7 Thermo Fisher Scientific Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.11 Chromsystems Instruments & Chemicals GmbH
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.12 Trivitron Healthcare
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.13 Baebies Inc
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
17 Global Newborn Screening Market - Distribution Model (Additional Insight)
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2023, the market attained a value of approximately USD 1.20 billion.
The market is expected to grow at a CAGR of 9% from 2024 to 2032 to reach a value of USD 2.60 billion by 2032.
The market is being aided by the improving health infrastructure in the developing countries and the growing cost-effectiveness of newborn screening.
The industry is expected to be driven by the growing development of advanced screening tests, the adoption of innovative technologies, and the increasing research activities to minimise the side-effects of newborn screening methods.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major technologies of newborn screening in the industry are tandem mass spectrometry, pulse oximetry, enzyme based assays, DNA assays, and electrophoresis.
The significant test types in the market are dry blood spot tests, critical congenital heart disease, and hearing screening tests.
The various products of newborn screening are instruments and reagents and assay kits.
The major players in the industry are Natus Medical, Inc., Masimo Corporation, AB Sciex, LLC, Medtronic PLC, Intelligent Hearing Systems Corporation, and Waters Corporation, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.